Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2880) 2880
Publication (273) 273
Newsletter (85) 85
Newspaper Article (23) 23
Book Review (19) 19
Book Chapter (8) 8
Magazine Article (8) 8
Dissertation (5) 5
Web Resource (4) 4
Trade Publication Article (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tazobactam (1648) 1648
humans (1219) 1219
index medicus (953) 953
piperacillin-tazobactam (791) 791
microbiology (786) 786
pharmacology & pharmacy (757) 757
infectious diseases (744) 744
penicillanic acid - analogs & derivatives (701) 701
piperacillin (670) 670
antibiotics (628) 628
male (572) 572
female (539) 539
anti-bacterial agents - therapeutic use (453) 453
microbial sensitivity tests (450) 450
middle aged (408) 408
anti-bacterial agents - pharmacology (376) 376
infections (358) 358
aged (351) 351
adult (338) 338
penicillanic acid - pharmacology (322) 322
piperacillin/tazobactam (309) 309
beta-lactamase inhibitors (305) 305
bacteria (275) 275
penicillanic acid - therapeutic use (272) 272
drug resistance (263) 263
health aspects (262) 262
anti-bacterial agents - administration & dosage (254) 254
piperacillin - therapeutic use (252) 252
resistance (252) 252
pharmacokinetics (250) 250
meropenem (247) 247
cefepime (244) 244
pseudomonas aeruginosa (241) 241
piperacillin - pharmacology (239) 239
ceftazidime (238) 238
research (237) 237
escherichia-coli (234) 234
mortality (228) 228
antimicrobial agents (225) 225
hospitals (221) 221
sulbactam (218) 218
enterobacteriaceae (209) 209
vancomycin (209) 209
patients (208) 208
infection (206) 206
pseudomonas-aeruginosa (206) 206
treatment outcome (205) 205
analysis (197) 197
pneumonia (197) 197
therapy (197) 197
risk factors (190) 190
imipenem (189) 189
clavulanic acid (184) 184
penicillanic acid - administration & dosage (181) 181
piperacillin - administration & dosage (181) 181
polycyclic compounds (179) 179
bacteremia (170) 170
drug resistance in microorganisms (169) 169
pseudomonas aeruginosa - drug effects (169) 169
care and treatment (168) 168
epidemiology (166) 166
adolescent (163) 163
dosage and administration (159) 159
biochemical phenomena, metabolism, and nutrition (157) 157
immunology (157) 157
cephalosporins (156) 156
retrospective studies (155) 155
pharmacodynamics (153) 153
drug therapy (152) 152
anti-bacterial agents - pharmacokinetics (150) 150
bacterial infections and mycoses (148) 148
aged, 80 and over (146) 146
medical research (145) 145
ciprofloxacin (142) 142
carbapenems (140) 140
prospective studies (139) 139
beta lactamases (136) 136
gram-negative bacteria (136) 136
susceptibility (136) 136
internal medicine (133) 133
sepsis (133) 133
amikacin (132) 132
bacterial infections - drug therapy (132) 132
drug therapy, combination (131) 131
anti-bacterial agents - adverse effects (130) 130
klebsiella-pneumoniae (129) 129
pediatrics (129) 129
animals (128) 128
escherichia coli - drug effects (125) 125
pathogens (125) 125
piperacillin - pharmacokinetics (125) 125
diagnosis (124) 124
medicine, experimental (124) 124
penicillanic acid - adverse effects (124) 124
penicillanic acid - pharmacokinetics (123) 123
antimicrobial resistance (120) 120
piperacillin - adverse effects (120) 120
risk-factors (120) 120
beta-lactamases - metabolism (117) 117
e coli (117) 117
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2819) 2819
French (43) 43
Spanish (43) 43
German (36) 36
Chinese (22) 22
Japanese (20) 20
Italian (9) 9
Turkish (7) 7
Portuguese (5) 5
Korean (3) 3
Czech (2) 2
Hungarian (2) 2
Polish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Evolution des consommations d'antibiotiques dans 115 etablissements de sante, Ile-de-France, 2013--2017
by L'heriteau, F and Nkoumazok, B and Gaudichon, A and Astagneau, P
Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S56
Le controle de la resistance aux antibiotiques (ATB) passe par une maitrise de la consommation des ATB (CAB). La surveillance en reseau des CAB dans les... 
Tazobactam
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Population pharmacokinetics of tazobactam/ceftolozane in Japanese patients with complicated urinary tract infection and complicated intra-abdominal infection
by Kakara, Makoto and Larson, Kajal and Feng, Hwa-ping and Shiomi, Mari and Yoshitsugu, Hiroyuki and Rizk, Matthew L
Journal of Infection and Chemotherapy, ISSN 1341-321X, 03/2019, Volume 25, Issue 3, pp. 182 - 191
Tazobactam/ceftolozane is a combination of a β-lactamase inhibitor and a cephalosporin antibiotic, with recommended dosage for patients with normal renal... 
Complicated intra-abdominal infection (cIAI) | Population pharmacokinetics | Japanese patients | Empirical Bayes estimate analysis | Complicated urinary tract infection (cUTI) | Ceftolozane | CLEARANCE | INFECTIOUS DISEASES | CXA-101 | SAFETY | RENAL-FUNCTION | COMBINATION | CEPHALOSPORIN | CEFTOLOZANE/TAZOBACTAM | PSEUDOMONAS-AERUGINOSA | PHARMACOLOGY & PHARMACY | TAZOBACTAM | ENTEROBACTERIACEAE | Japan - epidemiology | Anti-Bacterial Agents - blood | Humans | Middle Aged | Male | Tazobactam - blood | Cephalosporins - therapeutic use | Tazobactam - pharmacokinetics | Young Adult | Anti-Bacterial Agents - therapeutic use | Tazobactam - administration & dosage | Cephalosporins - blood | Aged, 80 and over | Adult | Cephalosporins - pharmacokinetics | Female | Cephalosporins - administration & dosage | Models, Statistical | Intraabdominal Infections - epidemiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Tazobactam - therapeutic use | Anti-Bacterial Agents - pharmacokinetics | Bayes Theorem | Aged | Anti-Bacterial Agents - administration & dosage | Intraabdominal Infections - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. The Cost of Vancomycin and Piperacillin/Tazobactam Treatment
by Zachary I Willis and Ravi Jhaveri
JAMA Pediatrics, ISSN 2168-6203, 05/2018, Volume 172, Issue 5, p. 494
Tazobactam | Piperacillin | Vancomycin
Journal Article
Details down arrow
4. The Cost of Vancomycin and Piperacillin/Tazobactam Treatment-Reply
by Kevin J Downes and Benjamin L Laskin and Brian T Fisher
JAMA Pediatrics, ISSN 2168-6203, 05/2018, Volume 172, Issue 5, p. 494
Tazobactam | Piperacillin | Vancomycin
Journal Article
Details down arrow
5. Full Text The authors reply
by Rhodes, Nathaniel J and Liu, Jiajun and Lipman, Jeffrey and Roberts, Jason A
Critical care medicine, 07/2018, Volume 46, Issue 7, p. e725
Tazobactam | Piperacillin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Piperacillin‐tazobactam drug‐induced immune haemolysis in a case of paroxysmal nocturnal haemoglobinuria
by McDonald, L and Brodie, R and Murphy, K and Wright, P and Webster, R and Fitzgerald, J
Transfusion Medicine, ISSN 0958-7578, 04/2019, Volume 29, Issue 2, pp. 138 - 140
HEMATOLOGY | ANEMIA | Tazobactam
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial
by Harris, PNA and Tambyah, PA and Lye, DC and Mo, Y and Lee, TH and Yilmaz, M and Alenazi, TH and Arabi, Y and Falcone, M and Bassetti, M and Righi, E and Rogers, BA and Kanj, S and Bhally, H and Iredell, J and Mendelson, M and Boyles, TH and Looke, D and Miyakis, S and Walls, G and Al Khamis, M and Zikri, A and Crowe, A and Ingram, P and Daneman, N and Griffin, P and Athan, E and Lorenc, P and Baker, P and Roberts, L and Beatson, SA and Peleg, AY and Harris-Brown, T and Paterson, DL and Merino Trial Investigators and Australasian Soc Infect Dis Clinic and MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) and for the MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | EXTENDED-SPECTRUM | CEFEPIME | THERAPY | BACTEREMIA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | EXTENSION | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Randomization | Cephalosporins | E coli | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Original Investigation | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Prolonged Infusions: The Significance of How
by Colton, Benjamin
Critical Care Medicine, ISSN 0090-3493, 02/2018, Volume 46, Issue 2, pp. 333 - 335
Prolonged infusion | Continuous infusion | Piperacillintazobactam | Extended infusion | MORTALITY | extended infusion | piperacillin-tazobactam | continuous infusion | prolonged infusion | CRITICAL CARE MEDICINE | Piperacillin, Tazobactam Drug Combination | Tazobactam | Anti-Bacterial Agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Un piege diagnostique : le syndrome de transillumination bilaterale aigue de l'iris
by Giorgiutti, S and Krencker, D and Diallo, A.O and Ballonzoli, L and Poindron, V
La Revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, p. A119
Nous rapportons le cas d'une entite clinique de description recente pouvant A*tre confondue avec une uveite anterieure aigue : le syndrome de transillumination... 
Corticosteroids | Tazobactam | Prednisone
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Paraosteoarthropathie neurogene : une cause rare de fievre prolongee chez le paraplegique
by Maquet, J and Paricaud, K and Bories, E and Couture, G and Zabraniecki, L and Nougarolis, F and Beck, C and Aizel, G and Astudillo, L and Pugnet, G and Moulis, G and Sailler, L
La Revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, p. A210
La fievre prolongee d'origine indeterminee est un defi diagnostique en medecine interne. En cas de paraplegie avec anesthesie associee, la pauvrete des signes... 
Tazobactam | Anticoagulants (Medicine) | Colchicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Measurement of ceftolozane and tazobactam concentrations in plasma by UHPLC-MS/MS. Clinical application in the management of difficult-to-treat osteoarticular infections
by Rigo-Bonnin, Raúl and Gomez-Junyent, Joan and García-Tejada, Laura and Benavent, Eva and Soldevila, Laura and Tubau, Fe and Murillo, Oscar
Clinica Chimica Acta, ISSN 0009-8981, 01/2019, Volume 488, pp. 50 - 60
Ceftolozane, in combination with the β-lactamase inhibitor tazobactam, is a new option in the pipeline against multidrug-resistant Gram-negative bacilli. As... 
Therapeutic drug monitoring | UHPLC-MS/MS | Tazobactam | Ceftolozane | Osteoarticular infections | PSEUDOMONAS-AERUGINOSA | VALIDATION | BETA-LACTAM ANTIBIOTICS | CONTINUOUS-INFUSION | MEDICAL LABORATORY TECHNOLOGY | COMBINATION | Tazobactam - chemistry | Staphylococcal Infections - drug therapy | Anti-Bacterial Agents - blood | Humans | Cephalosporins - chemistry | Chromatography, High Pressure Liquid | Tazobactam - blood | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Tandem Mass Spectrometry | Tazobactam - therapeutic use | Anti-Bacterial Agents - chemistry | Cephalosporins - blood | Adult | Aged | Molecular Structure | Measurement | Beta lactamases | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text False-positive results in the galactomannan Platelia™ Aspergillus assay with generic piperacillin/tazobactam
by Ortiz-Brizuela, Edgar and Rangel-Cordero, Andrea and Ponce-de-León, Alfredo and Sierra-Madero, Juan
Revista Iberoamericana de Micología, ISSN 1130-1406, 2018, Volume 36, Issue 1, pp. 51 - 52
Infectious Disease | TAZOBACTAM | MYCOLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Salvage Therapy with CeftolozaneTazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections
by Caston, JJ and De la Torre, A and Ruiz-Camps, I and Sorli, ML and Torres, V and Torre-Cisneros, J
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 03/2017, Volume 61, Issue 3
Infections caused by multidrug-resistant Pseudomonas aeruginosa (MDRPA) present a major problem for therapeutic management. We report here our experience with... 
URINARY-TRACT-INFECTIONS | CEFTOLOZANE/TAZOBACTAM | ceftolozane-tazobactam | DOUBLE-BLIND | Pseudomonas aeruginosa | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | salvage therapy | COMBINATION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Evaluation de la strategie d'arrAt de l'antibiotherapie selon les recommandations de l'ECIL4 chez les patients neutropeniques traites pour une hemopathie maligne : analyse descriptive d'une serie de 59 cas
by Le Bourgeois, A and Paret, R and Peterlin, P and Deschanvres, C and Boutoille, D and Asseray, N and Le Gouill, S and Lecomte, R and Gastinne, T and Gaborit, B
Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S24
En cas d'aplasie febrile, le maintien d'une antibiotherapie a large spectre jusqu'a la sortie d'aplasie etait jusqu'a recemment recommande. L'ECIL4 (European... 
Tazobactam | Valuation | Leukemia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Caracteristiques des meningites a Klebsiella pneumoniae et Klebsiella oxytoca
by Huriez, P and Cattoir, V and Corvec, S and Le Brun, C and Janvier, F and Morand, P and Grillon, A and Bille, E and Le Monnier, A and Pilmis, B
Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S98
Materiels et methodes Les meningites a Klebsiella sp. sont tres peu decrites et pourtant la mortalite est elevee. Elles semblent survenir avant 1 an, ou aux... 
Pneumonia | Tazobactam | Bacterial pneumonia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Acute kidney injury incidence in patients with hematological malignancy treated with meropenem and vancomycin for febrile neutropenia
by Kobayashi, Shunsuke and Yasu, Takeo and Momo, Kenji
Clinical nephrology, ISSN 0301-0430, 06/2019, Volume 91, Issue 6, pp. 392 - 394
PIPERACILLIN-TAZOBACTAM | UROLOGY & NEPHROLOGY
Journal Article
Details down arrow
17. Full Text Piperacillin-Tazobactam: Extended Infusion Versus Continuous Infusion
by Messori, Andrea and Tulli, Giorgio and Caccese, Erminia and Trippoli, Sabrina and Marinai, Claudio
Critical Care Medicine, ISSN 0090-3493, 07/2018, Volume 46, Issue 7, pp. e725 - e725
CRITICAL CARE MEDICINE | Penicillanic Acid | Piperacillin, Tazobactam Drug Combination | Tazobactam | Piperacillin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text CLINICAL EFFICACY AND COST‐EFFECTIVENESS ANALYSIS OF CEFEPIME OR PIPERACILLIN/TAZOBACTAM BOTH WITH CIPROFLOXACIN IN MICU PATIENTS WITH SEVERE PNEUMONIA
Respirology, ISSN 1323-7799, 11/2018, Volume 23, Issue S2, pp. 193 - 193
Tazobactam | Cefepime | Ciprofloxacin | Piperacillin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Acquisition of extended-spectrum -lactamase ges-6 leading to resistance to ceftolozane-tazobactam combination in Pseudomonas Aeruginosa
by Poirel, Laurent and De La Rosa, José-Manuel Ortiz and Kieffer, Nicolas and Dubois, Véronique and Jayol, Aurélie and Nordmanna, Patrice
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2019, Volume 63, Issue 1
Ceftolozane-tazobactam | ESBL | Pseudomonas aeruginosa | GES-6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta -lactamase-producing Enterobacteriaceae
by Thomson, KS and Moland, ES
Antimicrobial Agents & Chemotherapy, ISSN 0066-4804, 12/2001, Volume 45, Issue 12, pp. 3548 - 3554
There is little information about the clinical effectiveness of cefepime and piperacillin-tazobactam in the treatment of infections caused by extended-spectrum... 
Tazobactam
Journal Article
Details down arrow
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.